Skip to content

Heart-Kidney Harmonizing Formula for the Treatment of Chronic Insomnia in the Elderly: A Clinical Study

Heart-Kidney Harmonizing Formula for the Treatment of Chronic Insomnia in the Elderly: A Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000902
Enrollment
Unknown
Registered
2025-05-07
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia in the Elderly

Interventions

Control group:Melatonin
Experimental group:Heart-Kidney Harmonizing Formula

Sponsors

Tongchuan Hospital of Traditional Chinese Medicine(Sun Simiao Hospital Beijing University of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Western medical diagnostic criteria for chronic insomnia;(2) Meet the diagnostic criteria for chronic insomnia with Heart-Kidney Disharmony Syndrome in Traditional Chinese Medicine (TCM);(3) Aged 60 to 75 years regardless of gender;(4) Pittsburgh Sleep Quality Index (PSQI) score = 7;(5) Possess sufficient cognitive ability to understand relevant scales;(6) Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary insomnia caused by other physical diseases mental illnesses or external interference factors;(2) Patients diagnosed with moderate to severe anxiety or depression based on anxiety and depression scales;(3) Patients with severe underlying diseases including but not limited to cardiac pulmonary renal gastrointestinal hematological neuropsychiatric immunological metabolic malignant tumors or severe malnutrition;(4) Patients who are unable to cooperate due to their mental state such as those with psychiatric disorders lack of insight or inability to express themselves clearly;(5) Patients allergic to the products involved in the treatment regimen;(6) Individuals deemed unsuitable for using the drugs involved in the treatment regimen according to the investigators judgment (e.g. those who have taken Western sedative-hypnotic medications within the past week);(7) Individuals currently participating in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
TCM Syndrome Score;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Measure Yourself Medical Outcomes Profile;Epworth Sleepiness Scale;

Countries

China

Contacts

Public ContactXiaohong Gu

Beijing University of Chinese Medicine

guxh1003@126.com13910783120

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026